Abbott Labs said on Wednesday that third-quarter profit rose 37 percent on strong demand for its Humira arthritis drug and nutritional products, as well as gains from a settlement with Medtronic.
Intel reported profit and revenue that both substantially outpaced expectations Tuesday as the company's shares were halted in late trading.
| As of Wednesday, October 14th: |
